Defibrillator Market - Global Forecast to 2030
商品番号 : SMB-9272
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年8月 |
| ページ数 | 296 |
| 図表数 | 394 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
この調査レポートでは、除細動器市場を製品別（植込み型除細動器［経静脈植込み型除細動器（両室ICDS/心臓再同期療法除細動器、デュアルチャンバーICDS、およびシングルチャンバーICDS）］、皮下植込み型除細動器）、体外除細動器［手動体外除細動器、自動体外除細動器（半自動体外除細動器、全自動体外除細動器）］、ウェアラブル除細動器}、患者タイプ別（成人、小児）、エンドユーザー別（病院・診療所、心臓センター、病院前診療所、公共アクセス市場、在宅ケア施設、その他のエンドユーザー）、および地域別（北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東・アフリカ）に分類しています。本レポートは、除細動器市場の成長に影響を与える主要な要因（推進要因、制約要因、課題、機会など）に関する詳細な情報を網羅しています。また、この市場における主要プレーヤーの競合分析に加え、各社の企業概要、製品ラインナップ、主要な市場戦略も提供しています。
世界の除細動器市場は、2025年の119億9,000万米ドルから2030年には164億4,000万米ドルに達し、予測期間中は年平均成長率（CAGR）6.5%で成長すると予測されています。除細動器市場の成長は、心血管疾患患者の割合の増加、除細動器の技術進歩、そして公共機関および民間組織による無償の研修・プログラムの提供やパブリックアクセス除細動器（PAD）の普及促進に向けた取り組みの増加によって牽引されています。しかしながら、植込み型除細動器および自動体外式除細動器に関連する問題や頻繁な製品リコールが市場の成長を阻害しています。
The global defibrillator market is expected to reach USD 16.44 billion by 2030 from USD 11.99 billion in 2025, at a CAGR of 6.5% during the forecast period. The growth in the defibrillator market is driven by the increasing proportion of the population with cardiovascular diseases, technological advancements in defibrillators, and rising initiatives by public and private organizations to provide free training and programs, as well as enhance the implementation of public access defibrillators (PADs). However, issues related to implantable and automated external defibrillators and frequent product recalls have impeded market growth.
The implantable cardioverter defibrillators segment accounted for the largest share of the global market in 2024.
Based on product, the defibrillator market is broadly segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators. ICDs are further divided into transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators, whereas external defibrillators are divided into manual AEDs, automated AEDs, and wearable defibrillators. The ICDs segment accounted for the largest global defibrillator market share in 2024. Technological advancements in implantable defibrillators, rising awareness among cardiologists about the benefits pertaining to subcutaneous ICDs, and the launch of technologically advanced ICDs.
The adult segment dominated the defibrillator market based on the patient type in 2024.
The defibrillator market is segmented into adult and pediatric patients based on patient type. The adult patients segment dominated the global defibrillator market in 2024. The increasing incidence of cardiovascular disease in the adult population, rapid growth in the geriatric population, which is highly susceptible to sudden cardiac arrest, and the increasing number of implantations of ICDs in adult patients are likely to fuel the growth of the segment.
North America is expected to account for the highest market share in the defibrillator market during the forecast period.
Based on the region, the global defibrillator market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to witness a high market share during the forecast period. This can be attributed to factors such as the rising adoption of advanced defibrillators, increasing efforts by governments to provide the necessary care to cardiac arrest patients, the strong foothold of market players, favorable reimbursement programs, and an increase in the incidence of coronary artery diseases.
Breakdown of supply-side primary interviews by company type, designation, and region:
- By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
- By Designation: C Level (35%), Director Level (25%), and Others (40%)
- By Region: North America (40%), Asia Pacific (25%), Europe (20%), Latin America (10%), and Middle East & Africa (5%)
Prominent companies include Medtronic (Ireland), Stryker (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Nihon Kohden Corporation (Japan), Biotronik (Germany), and CU Medical Systems, Inc. (South Korea).
Research Coverage
This research report categorizes the defibrillator market by Product {Implantable cardioverter defibrillators [Transvenous implantable cardioverter defibrillators (Biventricular ICDS/cardiac resynchronization therapy defibrillators, dual-chamber ICDS, and single-chamber ICDS)], Subcutaneous implantable cardioverter defibrillators) External defibrillators [Manual External defibrillators, Automated external defibrillators (semi-automated external defibrillators, fully automated external defibrillators)], Wearable cardioverter defibrillators}, Patient type (Adult, Pediatric), End Users (Hospitals & Clinics, Cardiac centers, Prehospital settings, Public access markets, Home care settings, and Other end users), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the defibrillators market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will help established firms, new entrants, and smaller firms gauge the pulse of the market, which in turn would help them gain a more significant share of the market. Firms purchasing the report could use one or any combination of the strategies mentioned below to strengthen their position in the market.
This report provides insights into the following pointers:
- Analysis of key drivers (rising prevalence of cardiovascular disease, increase in geriatric patient population, a strong focus of government to boost the installation of public access defibrillators, rising defibrillators training & programs, and expanding healthcare infrastructure), restraints (frequent product recalls, issues related to implantable and automated external defibrillators), opportunities (emerging countries, ongoing developments in ICDs/CRT-Ds, mergers and acquisitions among market players), and challenges (frequent product recalls and lack of awareness about the cardiac arrest in emerging countries) influencing the growth of the defibrillators market
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the defibrillator market
- Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the defibrillator market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the defibrillator market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players
Table of Contents
1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
1.3 STUDY SCOPE 28
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 28
1.3.2 INCLUSIONS AND EXCLUSIONS 29
1.3.3 YEARS CONSIDERED 30
1.4 CURRENCY CONSIDERED 30
1.5 STAKEHOLDERS 31
1.6 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
2.1.1 SECONDARY DATA 34
2.1.2 PRIMARY RESEARCH 35
2.1.2.1 Key data from primary sources 35
2.1.2.2 Key industry insights 36
2.2 MARKET SIZE ESTIMATION METHODOLOGY 37
2.2.1 PRODUCT-BASED MARKET ESTIMATION 39
2.2.2 END-USER-BASED MARKET ESTIMATION 39
2.2.3 PRIMARY RESEARCH VALIDATION 40
2.2.4 TOP-DOWN APPROACH 41
2.2.5 GROWTH RATE PROJECTIONS 41
2.3 DATA TRIANGULATION 42
2.4 RESEARCH ASSUMPTIONS 44
2.5 RESEARCH LIMITATIONS 44
2.6 RISK ANALYSIS 45
3 EXECUTIVE SUMMARY 46
4 PREMIUM INSIGHTS 52
4.1 DEFIBRILLATOR MARKET OVERVIEW 52
4.2 ASIA PACIFIC DEFIBRILLATOR MARKET, BY COUNTRY AND END USER 53
4.3 GEOGRAPHIC SNAPSHOT OF DEFIBRILLATOR MARKET 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
5.2.1 DRIVERS 56
5.2.1.1 Growing prevalence of cardiovascular diseases 56
5.2.1.2 Increasing focus on public-access defibrillators 56
5.2.1.3 Training and awareness programs on defibrillators 57
5.2.2 RESTRAINTS 58
5.2.2.1 Frequent product recalls 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 Untapped growth potential in emerging markets 59
5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds 59
5.2.4 CHALLENGES 60
5.2.4.1 Inadequate awareness of sudden cardiac arrest and limited access to healthcare 60
5.2.4.2 Challenges associated with pricing pressure 60
5.3 INDUSTRY TRENDS 61
5.3.1 NEXT GEN AI-ENABLED PATCH WEARABLE CARDIOVERTER DEFIBRILLATORS 61
5.3.2 CONNECTED AED ECOSYSTEM 61
5.3.3 EXPANSION IN EMERGING MARKETS AND PUBLIC ACCESS 61
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 62
5.5 PRICING ANALYSIS 62
5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 63
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION 64
5.6 VALUE CHAIN ANALYSIS 65
5.7 SUPPLY CHAIN ANALYSIS 66
5.8 ECOSYSTEM ANALYSIS 67
5.9 INVESTMENT AND FUNDING SCENARIO 68
5.10 TECHNOLOGY ANALYSIS 68
5.10.1 KEY TECHNOLOGIES 68
5.10.1.1 Electrodes and gel pad technology 68
5.10.1.2 Handheld portable defibrillator 69
5.10.2 COMPLEMENTARY TECHNOLOGIES 69
5.10.2.1 Cardiopulmonary Resuscitation (CPR) feedback technology 69
5.10.2.2 Automated self-testing and device readiness monitoring 69
5.10.3 ADJACENT TECHNOLOGIES 70
5.10.3.1 Electronic Health Record (EHR) integration 70
5.11 PATENT ANALYSIS 70
5.11.1 JURISDICTION AND TOP APPLICANT ANALYSIS 70
5.12 TRADE ANALYSIS 74
5.12.1 IMPORT DATA FOR HS CODE 901890 74
5.12.2 EXPORT DATA FOR HS CODE 901890 74
5.13 KEY CONFERENCES AND EVENTS, 2025–2026 75
5.14 REGULATORY LANDSCAPE 76
5.14.1 REGULATORY FRAMEWORK 76
5.14.1.1 North America 76
5.14.1.1.1 US 76
5.14.1.1.2 Canada 76
5.14.1.2 Europe 76
5.14.1.3 Asia Pacific 76
5.14.1.4 Latin America 77
5.14.1.5 Middle East & Africa 77
5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
5.15 PORTER’S FIVE FORCES ANALYSIS 81
5.15.1 BARGAINING POWER OF SUPPLIERS 82
5.15.2 BARGAINING POWER OF BUYERS 82
5.15.3 THREAT OF NEW ENTRANTS 83
5.15.4 THREAT OF SUBSTITUTES 83
5.15.5 INTENSITY OF COMPETITIVE RIVALRY 83
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 84
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 84
5.16.2 BUYING CRITERIA 85
5.17 REIMBURSEMENT SCENARIO 86
5.18 UNMET NEEDS/END-USER EXPECTATIONS 87
5.19 IMPACT OF AI/GEN AI ON DEFIBRILLATOR MARKET 88
5.19.1 INTRODUCTION 88
5.19.2 MARKET POTENTIAL OF AI IN DEFIBRILLATORS 88
5.19.3 AI USE CASES 88
5.19.4 KEY COMPANIES IMPLEMENTING AI 89
5.20 IMPACT OF 2025 US TARIFF 90
5.20.1 INTRODUCTION 90
5.20.2 KEY TARIFF RATES 91
5.20.3 PRICE IMPACT ANALYSIS 91
5.20.4 IMPACT ON COUNTRY/REGION 92
5.20.5 IMPACT ON END-USE SEGMENTS 95
6 DEFIBRILLATOR MARKET, BY PRODUCT 96
6.1 INTRODUCTION 97
6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 97
6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 100
6.2.1.1 Biventricular ICDs/Cardiac resynchronization therapy defibrillators 102
6.2.1.1.1 Growing improvements in battery technology to boost market 102
6.2.1.2 Dual-chamber ICDs 103
6.2.1.2.1 Ability to reduce incidence of inappropriate shocks to drive market 103
6.2.1.3 Single-chamber ICDs 105
6.2.1.3.1 Utilization of single-chamber ICDs for atrial monitoring to support growth 105
6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 106
6.2.2.1 Increasing preference for less-invasive approach to augment growth 106
6.3 EXTERNAL DEFIBRILLATORS 108
6.3.1 MANUAL EXTERNAL DEFIBRILLATORS 109
6.3.1.1 High portability and compact design to foster growth 109
6.3.2 AUTOMATED EXTERNAL DEFIBRILLATORS 111
6.3.2.1 Semi-automated external defibrillators 113
6.3.2.1.1 Growing initiatives for emergency medical services to fuel market 113
6.3.2.2 Fully automated external defibrillators 114
6.3.2.2.1 Rising installation of defibrillators in public places to favor growth 114
6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS 116
6.3.3.1 Increasing launches of wearable defibrillators to facilitate growth 116
7 DEFIBRILLATOR MARKET, BY PATIENT TYPE 118
7.1 INTRODUCTION 119
7.2 ADULT PATIENTS 119
7.2.1 INCREASING GERIATRIC POPULATION AND RISING BURDEN OF CARDIOVASCULAR DISEASES TO DRIVE MARKET 119
7.3 PEDIATRIC PATIENTS 120
7.3.1 RISING INCIDENCE OF PEDIATRIC HEART AILMENTS TO SUPPORT GROWTH 120
8 DEFIBRILLATOR MARKET, BY END USER 122
8.1 INTRODUCTION 123
8.2 HOSPITALS & CLINICS 123
8.2.1 HIGH VOLUME OF CARDIAC PROCEDURES TO EXPEDITE GROWTH 123
8.3 CARDIAC CENTERS 125
8.3.1 INCREASING CARDIOVASCULAR CASELOAD AND NEED FOR SPECIALIZED CARE TO BOOST MARKET 125
8.4 PREHOSPITAL SETTINGS 126
8.4.1 RISING FUNDING FOR EMERGENCY AMBULANCE SERVICES TO PROMOTE GROWTH 126
8.5 PUBLIC-ACCESS MARKETS 128
8.5.1 GROWING INCIDENCE OF SUDDEN CARDIAC ARRESTS TO PROPEL MARKET 128
8.6 HOME CARE SETTINGS 129
8.6.1 RISING ADOPTION OF HOME-AUTOMATED EXTERNAL DEFIBRILLATORS TO FOSTER GROWTH 129
8.7 OTHER END USERS 131
9 DEFIBRILLATOR MARKET, BY REGION 132
9.1 INTRODUCTION 133
9.2 NORTH AMERICA 134
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 134
9.2.2 US 138
9.2.2.1 High implant rates to contribute to growth 138
9.2.3 CANADA 141
9.2.3.1 High burden of cardiovascular diseases to support growth 141
9.3 EUROPE 144
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 144
9.3.2 GERMANY 148
9.3.2.1 Established healthcare system to favor growth 148
9.3.3 UK 151
9.3.3.1 Rising support from government & private organizations for accessibility of defibrillators to drive market 151
9.3.4 FRANCE 154
9.3.4.1 Favorable government initiatives to bolster growth 154
9.3.5 ITALY 157
9.3.5.1 High prevalence of out-of-hospital cardiac arrests to promote growth 157
9.3.6 SPAIN 160
9.3.6.1 Rising aging population to stimulate growth 160
9.3.7 REST OF EUROPE 163
9.4 ASIA PACIFIC 166
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 166
9.4.2 JAPAN 170
9.4.2.1 Booming geriatric population to foster growth 170
9.4.3 CHINA 173
9.4.3.1 Rising incidence of strokes to expedite growth 173
9.4.4 INDIA 176
9.4.4.1 Growing prevalence of cardiovascular diseases and government initiatives to drive market 176
9.4.5 AUSTRALIA 179
9.4.5.1 Increasing community access to defibrillators through policy and targeted funding to fuel market 179
9.4.6 SOUTH KOREA 182
9.4.6.1 Robust digital ecosystem and government-led health programs to boost market 182
9.4.7 REST OF ASIA PACIFIC 185
9.5 LATIN AMERICA 188
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 188
9.5.2 BRAZIL 191
9.5.2.1 Rising obesity rates to accelerate growth 191
9.5.3 MEXICO 194
9.5.3.1 Increasing infrastructure development to facilitate growth 194
9.5.4 REST OF LATIN AMERICA 197
9.6 MIDDLE EAST & AFRICA 200
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 200
9.6.2 GCC COUNTRIES 203
9.6.2.1 Kingdom of Saudi Arabia (KSA) 206
9.6.2.1.1 Expanding digital healthcare infrastructure to boost market 206
9.6.2.2 United Arab Emirates (UAE) 209
9.6.2.2.1 Increasing government investments for healthcare infrastructure to aid growth 209
9.6.2.3 Rest of GCC Countries 212
9.6.3 REST OF MIDDLE EAST & AFRICA 215
10 COMPETITIVE LANDSCAPE 219
10.1 INTRODUCTION 219
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 219
10.2.1 STRATEGIES ADOPTED BY KEY PLAYERS 219
10.2.2 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DEFIBRILLATOR MARKET 220
10.3 REVENUE ANALYSIS, 2022–2024 221
10.4 MARKET SHARE ANALYSIS, 2024 222
10.5 COMPANY VALUATION AND FINANCIAL METRICS 225
10.6 BRAND/PRODUCT COMPARISON 226
10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 226
10.7.1 STARS 226
10.7.2 EMERGING LEADERS 227
10.7.3 PERVASIVE PLAYERS 227
10.7.4 PARTICIPANTS 227
10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 228
10.7.5.1 Company footprint 228
10.7.5.2 Region footprint 228
10.7.5.3 Product footprint 229
10.7.5.4 Patient type footprint 230
10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 231
10.8.1 PROGRESSIVE COMPANIES 231
10.8.2 RESPONSIVE COMPANIES 231
10.8.3 DYNAMIC COMPANIES 231
10.8.4 STARTING BLOCKS 231
10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 233
10.8.5.1 Detailed list of key startups/SMEs 233
10.8.5.2 Competitive benchmarking of key startups/SMEs 233
10.9 COMPETITIVE SCENARIO 234
10.9.1 PRODUCT LAUNCHES AND APPROVALS 234
10.9.2 EXPANSIONS 235
10.9.3 DEALS 236
10.9.4 OTHER DEVELOPMENTS 237
11 COMPANY PROFILES 238
11.1 KEY PLAYERS 238
11.1.1 MEDTRONIC 238
11.1.1.1 Business overview 238
11.1.1.2 Products offered 239
11.1.1.3 Recent developments 242
11.1.1.3.1 Product launches and approvals 242
11.1.1.4 MnM view 243
11.1.1.4.1 Key strengths 243
11.1.1.4.2 Strategic choices 243
11.1.1.4.3 Weaknesses and competitive threats 243
11.1.2 BOSTON SCIENTIFIC CORPORATION 244
11.1.2.1 Business overview 244
11.1.2.2 Products offered 245
11.1.2.3 Recent developments 247
11.1.2.3.1 Deals 247
11.1.2.4 MnM view 247
11.1.2.4.1 Key strengths 247
11.1.2.4.2 Strategic choices 247
11.1.2.4.3 Weaknesses and competitive threats 247
11.1.3 ABBOTT 248
11.1.3.1 Business overview 248
11.1.3.2 Products offered 249
11.1.3.3 MnM view 250
11.1.3.3.1 Key strengths 250
11.1.3.3.2 Strategic choices 250
11.1.3.3.3 Weaknesses and competitive threats 250
11.1.4 ASAHI KASEI CORPORATION 251
11.1.4.1 Business overview 251
11.1.4.2 Products offered 252
11.1.4.3 MnM view 253
11.1.4.3.1 Key strengths 253
11.1.4.3.2 Strategic choices 253
11.1.4.3.3 Weaknesses and competitive threats 253
11.1.5 STRYKER 254
11.1.5.1 Business overview 254
11.1.5.2 Products offered 255
11.1.5.3 Recent developments 256
11.1.5.3.1 Product launches and approvals 256
11.1.5.3.2 Other developments 256
11.1.5.4 MnM view 256
11.1.5.4.1 Key strengths 256
11.1.5.4.2 Strategic choices 256
11.1.5.4.3 Weaknesses and competitive threats 256
11.1.6 KONINKLIJKE PHILIPS N.V. 257
11.1.6.1 Business overview 257
11.1.6.2 Products offered 258
11.1.6.3 Recent developments 259
11.1.6.3.1 Expansions 259
11.1.7 MICROPORT SCIENTIFIC CORPORATION 260
11.1.7.1 Business overview 260
11.1.7.2 Products offered 261
11.1.7.3 Recent developments 262
11.1.7.3.1 Product launches and approvals 262
11.1.8 NIHON KOHDEN CORPORATION 264
11.1.8.1 Business overview 264
11.1.8.2 Products offered 265
11.1.8.3 Recent developments 266
11.1.8.3.1 Expansions 266
11.1.9 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 267
11.1.9.1 Business overview 267
11.1.9.2 Products offered 268
11.1.9.3 Recent developments 269
11.1.9.3.1 Product launches and approvals 269
11.1.9.3.2 Other developments 269
11.1.10 BIOTRONIK 270
11.1.10.1 Business overview 270
11.1.10.2 Products offered 270
11.1.10.3 Recent developments 271
11.1.10.3.1 Expansions 271
11.1.11 CU MEDICAL SYSTEMS CO., LTD. 272
11.1.11.1 Business overview 272
11.1.11.2 Products offered 272
11.1.12 METSIS MEDIKAL 273
11.1.12.1 Business overview 273
11.1.12.2 Products offered 273
11.1.13 MEDIANA CO, LTD. 274
11.1.13.1 Business overview 274
11.1.13.2 Products offered 274
11.1.13.3 Recent developments 275
11.1.13.3.1 Other developments 275
11.1.14 PROGETTI SRL 276
11.1.14.1 Business overview 276
11.1.14.2 Products offered 276
11.1.14.3 Recent developments 277
11.1.14.3.1 Other developments 277
11.1.15 SCHILLER AG 278
11.1.15.1 Business overview 278
11.1.15.2 Products offered 278
11.1.15.3 Recent developments 279
11.1.15.3.1 Deals 279
11.1.15.3.2 Other developments 279
11.2 OTHER PLAYERS 280
11.2.1 BPL MEDICAL TECHNOLOGIES 280
11.2.2 METRAX GMBH 281
11.2.3 MS WESTFALIA GMBH 282
11.2.4 BEXEN CARDIO 283
11.2.5 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD. 284
11.2.6 AVIVE SOLUTIONS 284
11.2.7 AMI ITALIA 285
11.2.8 CORPULS 286
11.2.9 ALLIED MEDICAL LTD. 286
11.2.10 AXION CONCERN LLC 287
12 APPENDIX 288
12.1 DISCUSSION GUIDE 288
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 292
12.3 CUSTOMIZATION OPTIONS 294
12.4 RELATED REPORTS 294
12.5 AUTHOR DETAILS 295
LIST OF TABLES
TABLE 1 DEFIBRILLATOR MARKET: INCLUSIONS AND EXCLUSIONS 29
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 30
TABLE 3 DEFIBRILLATOR MARKET: RISK ANALYSIS 45
TABLE 4 PERCENTAGE OF GLOBAL POPULATION AGED 65 YEARS, BY REGION,
2022 VS. 2030 VS. 2050 56
TABLE 5 PRODUCT RECALLS BY US FDA, 2021–2024 58
TABLE 6 AVERAGE SELLING PRICE TREND OF DEFIBRILLATORS, BY KEY PLAYER,
2022–2024 (USD) 63
TABLE 7 AVERAGE SELLING PRICE TREND OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS), BY REGION, 2022–2024 (USD) 64
TABLE 8 AVERAGE SELLING PRICE TREND OF EXTERNAL DEFIBRILLATORS, BY REGION, 2022–2024 (USD) 64
TABLE 9 DEFIBRILLATOR MARKET: ROLE OF COMPANIES IN ECOSYSTEM 67
TABLE 10 DEFIBRILLATOR MARKET: INNOVATIONS AND PATENT REGISTRATIONS,
2023–2025 72
TABLE 11 IMPORT DATA FOR HS CODE 901890, BY COUNTRY,
2020–2024 (USD THOUSAND) 74
TABLE 12 EXPORT DATA FOR HS CODE 901890, BY COUNTRY,
2020–2024 (USD THOUSAND) 74
TABLE 13 DEFIBRILLATOR MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 75
TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 19 DEFIBRILLATOR MARKET: PORTER’S FIVE FORCES ANALYSIS 81
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DEFIBRILLATOR 85
TABLE 21 KEY BUYING CRITERIA FOR DEFIBRILLATOR, BY PRODUCT 86
TABLE 22 MEDICAL REIMBURSEMENT CODES FOR DEFIBRILLATOR PROCEDURES IN US 86
TABLE 23 DEFIBRILLATOR MARKET: UNMET NEEDS/END-USER EXPECTATIONS 87
TABLE 24 US ADJUSTED RECIPROCAL TARIFF RATES, 2024 91
TABLE 25 KEY PRODUCT-RELATED TARIFF EFFECTIVE DEFIBRILLATOR 91
TABLE 26 NORTH AMERICA: IMPACT OF US TARIFF ON CANADA 92
TABLE 27 ASIA PACIFIC: IMPACT OF US TARIFF ON CHINA, JAPAN, AND INDIA 93
TABLE 28 EUROPE: IMPACT OF US TARIFF ON GERMANY AND UK 94
TABLE 29 LATIN AMERICA: IMPACT OF US TARIFF ON MEXICO 94
TABLE 30 DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 97
TABLE 31 COMMERCIAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS AVAILABLE
IN MARKET 98
TABLE 32 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 98
TABLE 33 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 99
TABLE 34 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 100
TABLE 35 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 101
TABLE 36 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103
TABLE 37 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 104
TABLE 38 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 106
TABLE 39 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 107
TABLE 40 COMMERCIAL EXTERNAL DEFIBRILLATORS AVAILABLE IN MARKET 108
TABLE 41 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 108
TABLE 42 EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 43 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 110
TABLE 44 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 111
TABLE 45 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 112
TABLE 46 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 114
TABLE 47 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 115
TABLE 48 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 117
TABLE 49 DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 119
TABLE 50 DEFIBRILLATOR MARKET FOR ADULT PATIENTS, BY COUNTRY,
2023–2030 (USD MILLION) 120
TABLE 51 DEFIBRILLATOR MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY,
2023–2030 (USD MILLION) 121
TABLE 52 DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 123
TABLE 53 DEFIBRILLATOR MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,
2023–2030 (USD MILLION) 124
TABLE 54 DEFIBRILLATOR MARKET FOR CARDIAC CENTERS, BY COUNTRY,
2023–2030 (USD MILLION) 126
TABLE 55 DEFIBRILLATOR MARKET FOR PREHOSPITAL SETTINGS, BY COUNTRY,
2023–2030 (USD MILLION) 127
TABLE 56 DEFIBRILLATOR MARKET FOR PUBLIC-ACCESS MARKETS, BY COUNTRY,
2023–2030 (USD MILLION) 129
TABLE 57 DEFIBRILLATOR MARKET FOR HOME CARE SETTINGS, BY COUNTRY,
2023–2030 (USD MILLION) 130
TABLE 58 DEFIBRILLATOR MARKET FOR OTHER END USERS, BY COUNTRY,
2023–2030 (USD MILLION) 131
TABLE 59 DEFIBRILLATOR MARKET, BY REGION, 2023–2030 (USD MILLION) 133
TABLE 60 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2023–2030 (THOUSAND) 133
TABLE 61 NORTH AMERICA: DEFIBRILLATOR MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 135
TABLE 62 NORTH AMERICA: DEFIBRILLATOR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 136
TABLE 63 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 136
TABLE 64 NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 136
TABLE 65 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 137
TABLE 66 NORTH AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 137
TABLE 67 NORTH AMERICA: DEFIBRILLATOR MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 137
TABLE 68 NORTH AMERICA: DEFIBRILLATOR MARKET, BY END USER,
2023–2030 (USD MILLION) 138
TABLE 69 US: KEY MACROECONOMIC INDICATORS 139
TABLE 70 US: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 139
TABLE 71 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 139
TABLE 72 US: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 140
TABLE 73 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 140
TABLE 74 US: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 140
TABLE 75 US: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 141
TABLE 76 US: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 141
TABLE 77 CANADA: KEY MACROECONOMIC INDICATORS 142
TABLE 78 CANADA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 142
TABLE 79 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 142
TABLE 80 CANADA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 143
TABLE 81 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 143
TABLE 82 CANADA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 143
TABLE 83 CANADA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 144
TABLE 84 CANADA: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 144
TABLE 85 EUROPE: DEFIBRILLATOR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 86 EUROPE: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 145
TABLE 87 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 146
TABLE 88 EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 146
TABLE 89 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 146
TABLE 90 EUROPE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 147
TABLE 91 EUROPE: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 147
TABLE 92 EUROPE: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 147
TABLE 93 GERMANY: KEY MACROECONOMIC INDICATORS 148
TABLE 94 GERMANY: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 148
TABLE 95 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 149
TABLE 96 GERMANY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 149
TABLE 97 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 149
TABLE 98 GERMANY: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 150
TABLE 99 GERMANY: DEFIBRILLATOR MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 150
TABLE 100 GERMANY: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 150
TABLE 101 UK: KEY MACROECONOMIC INDICATORS 151
TABLE 102 UK: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 152
TABLE 103 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET, BY TYPE,
2023–2030 (USD MILLION) 152
TABLE 104 UK: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2023–2030 USD MILLION) 152
TABLE 105 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 153
TABLE 106 UK: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 153
TABLE 107 UK: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 153
TABLE 108 UK: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 154
TABLE 109 FRANCE: KEY MACROECONOMIC INDICATORS 154
TABLE 110 FRANCE: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 155
TABLE 111 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 155
TABLE 112 FRANCE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 155
TABLE 113 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 156
TABLE 114 FRANCE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 156
TABLE 115 FRANCE: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 156
TABLE 116 FRANCE: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 157
TABLE 117 ITALY: KEY MACROECONOMIC INDICATORS 158
TABLE 118 ITALY: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 158
TABLE 119 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 158
TABLE 120 ITALY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 159
TABLE 121 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 159
TABLE 122 ITALY: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 159
TABLE 123 ITALY: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 160
TABLE 124 ITALY: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 160
TABLE 125 SPAIN: KEY MACROECONOMIC INDICATORS 161
TABLE 126 SPAIN: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 161
TABLE 127 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 161
TABLE 128 SPAIN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 129 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 162
TABLE 130 SPAIN: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 162
TABLE 131 SPAIN: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 163
TABLE 132 SPAIN: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 163
TABLE 133 REST OF EUROPE: DEFIBRILLATOR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 164
TABLE 134 REST OF EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 164
TABLE 135 REST OF EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 164
TABLE 136 REST OF EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 165
TABLE 137 REST OF EUROPE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 165
TABLE 138 REST OF EUROPE: DEFIBRILLATOR MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 165
TABLE 139 REST OF EUROPE: DEFIBRILLATOR MARKET, BY END USER,
2023–2030 (USD MILLION) 166
TABLE 140 ASIA PACIFIC: DEFIBRILLATOR MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168
TABLE 141 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 168
TABLE 142 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 143 ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 169
TABLE 144 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 169
TABLE 145 ASIA PACIFIC: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 169
TABLE 146 ASIA PACIFIC: DEFIBRILLATOR MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 170
TABLE 147 ASIA PACIFIC: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 170
TABLE 148 JAPAN: KEY MACROECONOMIC INDICATORS 171
TABLE 149 JAPAN: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 171
TABLE 150 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 171
TABLE 151 JAPAN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172
TABLE 152 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 172
TABLE 153 JAPAN: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 172
TABLE 154 JAPAN: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 173
TABLE 155 JAPAN: DEFIBRILLATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 173
TABLE 156 CHINA: KEY MACROECONOMIC INDICATORS 174
TABLE 157 CHINA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 174
TABLE 158 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 174
TABLE 159 CHINA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175
TABLE 160 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 175
TABLE 161 CHINA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 175
TABLE 162 CHINA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 176
TABLE 163 CHINA: EXTERNAL DEFIBRILLATOR MARKET, BY END USER,
2023–2030 (USD MILLION) 176
TABLE 164 INDIA: KEY MACROECONOMIC INDICATORS 177
TABLE 165 INDIA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 177
TABLE 166 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 177
TABLE 167 INDIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178
TABLE 168 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178
TABLE 169 INDIA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 178
TABLE 170 INDIA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 179
TABLE 171 INDIA: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 179
TABLE 172 AUSTRALIA: KEY MACROECONOMIC INDICATORS 180
TABLE 173 AUSTRALIA: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 180
TABLE 174 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 175 AUSTRALIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 181
TABLE 176 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 181
TABLE 177 AUSTRALIA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 181
TABLE 178 AUSTRALIA: DEFIBRILLATOR MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 182
TABLE 179 AUSTRALIA: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 182
TABLE 180 SOUTH KOREA: KEY MACROECONOMIC INDICATORS 183
TABLE 181 SOUTH KOREA: DEFIBRILLATOR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 183
TABLE 182 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183
TABLE 183 SOUTH KOREA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184
TABLE 184 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 184
TABLE 185 SOUTH KOREA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184
TABLE 186 SOUTH KOREA: DEFIBRILLATOR MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 185
TABLE 187 SOUTH KOREA: DEFIBRILLATOR MARKET, BY END USER,
2023–2030 (USD MILLION) 185
TABLE 188 REST OF ASIA PACIFIC: DEFIBRILLATOR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 186
TABLE 189 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 190 REST OF ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 191 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 187
TABLE 192 REST OF ASIA PACIFIC: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 187
TABLE 193 REST OF ASIA PACIFIC: DEFIBRILLATOR MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 187
TABLE 194 REST OF ASIA PACIFIC: DEFIBRILLATOR MARKET, BY END USER,
2023–2030 (USD MILLION) 188
TABLE 195 LATIN AMERICA: DEFIBRILLATOR MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 189
TABLE 196 LATIN AMERICA: DEFIBRILLATOR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 189
TABLE 197 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 189
TABLE 198 LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 199 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 190
TABLE 200 LATIN AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190
TABLE 201 LATIN AMERICA: DEFIBRILLATOR MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 191
TABLE 202 LATIN AMERICA: DEFIBRILLATOR MARKET, BY END USER,
2023–2030 (USD MILLION) 191
TABLE 203 BRAZIL: KEY MACROECONOMIC INDICATORS 192
TABLE 204 BRAZIL: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 192
TABLE 205 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 192
TABLE 206 BRAZIL: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193
TABLE 207 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 193
TABLE 208 BRAZIL: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 193
TABLE 209 BRAZIL: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 194
TABLE 210 BRAZIL: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 194
TABLE 211 MEXICO: KEY MACROECONOMIC INDICATORS 195
TABLE 212 MEXICO: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 195
TABLE 213 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 195
TABLE 214 MEXICO: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 196
TABLE 215 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 196
TABLE 216 MEXICO: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 196
TABLE 217 MEXICO: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 197
TABLE 218 MEXICO: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 197
TABLE 219 REST OF LATIN AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 198
TABLE 220 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 221 REST OF LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198
TABLE 222 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 199
TABLE 223 REST OF LATIN AMERICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 199
TABLE 224 REST OF LATIN AMERICA: DEFIBRILLATOR MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 199
TABLE 225 REST OF LATIN AMERICA: DEFIBRILLATOR MARKET, BY END USER,
2023–2030 (USD MILLION) 200
TABLE 226 MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY REGION,
2023–2030 (USD MILLION) 201
TABLE 227 MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 201
TABLE 228 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201
TABLE 229 MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 230 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 202
TABLE 231 MIDDLE EAST & AFRICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 202
TABLE 232 MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 203
TABLE 233 MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY END USER,
2023–2030 (USD MILLION) 203
TABLE 234 GCC COUNTRIES: DEFIBRILLATOR MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 204
TABLE 235 GCC COUNTRIES: DEFIBRILLATOR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 204
TABLE 236 GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 204
TABLE 237 GCC COUNTRIES: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 238 GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 205
TABLE 239 GCC COUNTRIES: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205
TABLE 240 GCC COUNTRIES: DEFIBRILLATOR MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 206
TABLE 241 GCC COUNTRIES: DEFIBRILLATOR MARKET, BY END USER,
2023–2030 (USD MILLION) 206
TABLE 242 KINGDOM OF SAUDI ARABIA (KSA): KEY MACROECONOMIC INDICATORS 207
TABLE 243 KINGDOM OF SAUDI ARABIA (KSA): DEFIBRILLATOR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 207
TABLE 244 KINGDOM OF SAUDI ARABIA (KSA): IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207
TABLE 245 KINGDOM OF SAUDI ARABIA (KSA): TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 208
TABLE 246 KINGDOM OF SAUDI ARABIA (KSA): EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 208
TABLE 247 KINGDOM OF SAUDI ARABIA (KSA): AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 208
TABLE 248 KINGDOM OF SAUDI ARABIA (KSA): DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 209
TABLE 249 KINGDOM OF SAUDI ARABIA (KSA): DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 209
TABLE 250 UAE: KEY MACROECONOMIC INDICATORS 210
TABLE 251 UAE: DEFIBRILLATOR MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 210
TABLE 252 UAE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 210
TABLE 253 UAE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 254 UAE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211
TABLE 255 UAE: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 211
TABLE 256 UAE: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 212
TABLE 257 UAE: DEFIBRILLATOR MARKET, BY END USER, 2023–2030 (USD MILLION) 212
TABLE 258 REST OF GCC COUNTRIES: DEFIBRILLATOR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 213
TABLE 259 REST OF GCC COUNTRIES: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 213
TABLE 260 REST OF GCC COUNTRIES: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 213
TABLE 261 REST OF GCC COUNTRIES: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2023–2030 (USD MILLION) 214
TABLE 262 REST OF GCC COUNTRIES: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 214
TABLE 263 REST OF GCC COUNTRIES: DEFIBRILLATOR MARKET, BY PATIENT TYPE,
2023–2030 (USD MILLION) 214
TABLE 264 REST OF GCC COUNTRIES: DEFIBRILLATOR MARKET, BY END USER,
2023–2030 (USD MILLION) 215
TABLE 265 REST OF MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 216
TABLE 266 REST OF MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 216
TABLE 267 REST OF MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 216
TABLE 268 REST OF MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 269 REST OF MIDDLE EAST & AFRICA: AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217
TABLE 270 REST OF MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION) 217
TABLE 271 REST OF MIDDLE EAST & AFRICA: DEFIBRILLATOR MARKET, BY END USER,
2023–2030 (USD MILLION) 218
TABLE 272 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN
DEFIBRILLATOR MARKET 220
TABLE 273 IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICDS) MARKET:
DEGREE OF COMPETITION 222
TABLE 274 EXTERNAL DEFIBRILLATOR MARKET: DEGREE OF COMPETITION 223
TABLE 275 DEFIBRILLATOR MARKET: REGION FOOTPRINT 228
TABLE 276 DEFIBRILLATOR MARKET: PRODUCT FOOTPRINT 229
TABLE 277 DEFIBRILLATOR MARKET: PATIENT TYPE FOOTPRINT 230
TABLE 278 DEFIBRILLATOR MARKET: DETAILED LIST OF KEY STARTUPS/SMES 233
TABLE 279 DEFIBRILLATOR MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 233
TABLE 280 DEFIBRILLATOR MARKET: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–MAY 2025 234
TABLE 281 DEFIBRILLATOR MARKET: EXPANSIONS, JANUARY 2022–MAY 2025 235
TABLE 282 DEFIBRILLATOR MARKET: DEALS, JANUARY 2022–MAY 2025 236
TABLE 283 DEFIBRILLATOR MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 237
TABLE 284 MEDTRONIC: COMPANY OVERVIEW 238
TABLE 285 MEDTRONIC: PRODUCTS OFFERED 239
TABLE 286 MEDTRONIC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022– MAY 2025 242
TABLE 287 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 244
TABLE 288 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 245
TABLE 289 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–MAY 2025 247
TABLE 290 ABBOTT: COMPANY OVERVIEW 248
TABLE 291 ABBOTT: PRODUCTS OFFERED 249
TABLE 292 ASAHI KASEI CORPORATION: COMPANY OVERVIEW 251
TABLE 293 ASAHI KASEI CORPORATION: PRODUCTS OFFERED 252
TABLE 294 STRYKER: COMPANY OVERVIEW 254
TABLE 295 STRYKER: PRODUCTS OFFERED 255
TABLE 296 STRYKER: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MAY 2025 256
TABLE 297 STRYKER: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 256
TABLE 298 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 257
TABLE 299 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 258
TABLE 300 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2022–MAY 2025 259
TABLE 301 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 260
TABLE 302 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 261
TABLE 303 MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MAY 2025 262
TABLE 304 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 264
TABLE 305 NIHON KOHDEN CORPORATION: PRODUCTS OFFERED 265
TABLE 306 NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2022–MARCH 2025 266
TABLE 307 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 267
TABLE 308 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 268
TABLE 309 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MAY 2025 269
TABLE 310 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 269
TABLE 311 BIOTRONIK: COMPANY OVERVIEW 270
TABLE 312 BIOTRONIK: PRODUCTS OFFERED 270
TABLE 313 BIOTRONIK: EXPANSIONS, JANUARY 2022–MAY 2025 271
TABLE 314 CU MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW 272
TABLE 315 CU MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED 272
TABLE 316 METSIS MEDIKAL: COMPANY OVERVIEW 273
TABLE 317 METSIS MEDIKAL: PRODUCTS OFFERED 273
TABLE 318 MEDIANA CO., LTD.: COMPANY OVERVIEW 274
TABLE 319 MEDIANA CO., LTD.: PRODUCTS OFFERED 274
TABLE 320 MEDIANA CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 275
TABLE 321 PROGETTI SRL: COMPANY OVERVIEW 276
TABLE 322 PROGETTI SRL: PRODUCTS OFFERED 276
TABLE 323 PROGETTI SRL: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 277
TABLE 324 SCHILLER AG: COMPANY OVERVIEW 278
TABLE 325 SCHILLER AG: PRODUCTS OFFERED 278
TABLE 326 SCHILLER AG.: DEALS, JANUARY 2022–MAY 2025 279
TABLE 327 SCHILLER AG.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 279
TABLE 328 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW 280
TABLE 329 METRAX GMBH: COMPANY OVERVIEW 281
TABLE 330 MS WESTFALIA GMBH: COMPANY OVERVIEW 282
TABLE 331 BEXEN CARDIO: COMPANY OVERVIEW 283
TABLE 332 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.: COMPANY OVERVIEW 284
TABLE 333 AVIVE SOLUTIONS: COMPANY OVERVIEW 284
TABLE 334 AMI ITALIA: COMPANY OVERVIEW 285
TABLE 335 CORPLUS: COMPANY OVERVIEW 286
TABLE 336 ALLIED MEDICAL LTD.: COMPANY OVERVIEW 286
TABLE 337 AXION CONCERN LLC: COMPANY OVERVIEW 287
LIST OF FIGURES
FIGURE 1 DEFIBRILLATOR MARKET SEGMENTATION AND REGIONAL SCOPE 28
FIGURE 2 DEFIBRILLATOR MARKET: YEARS CONSIDERED 30
FIGURE 3 DEFIBRILLATOR MARKET: RESEARCH DESIGN 33
FIGURE 4 DEFIBRILLATOR MARKET: KEY DATA FROM PRIMARY SOURCES 35
FIGURE 5 DEFIBRILLATOR MARKET: INSIGHTS FROM PRIMARIES 36
FIGURE 6 DEFIBRILLATOR MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
(SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS) 37
FIGURE 7 DEFIBRILLATOR MARKET: BREAKDOWN OF PRIMARY INTERVIEWS 37
FIGURE 8 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 38
FIGURE 9 DEFIBRILLATOR MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2024 39
FIGURE 10 DEFIBRILLATOR MARKET: MARKET SIZE ESTIMATION 40
FIGURE 11 DEFIBRILLATOR MARKET: TOP-DOWN APPROACH 41
FIGURE 12 DEFIBRILLATOR MARKET: CAGR PROJECTIONS (SUPPLY SIDE) 42
FIGURE 13 DATA TRIANGULATION METHODOLOGY 42
FIGURE 14 DEFIBRILLATOR MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 46
FIGURE 15 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS) MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 47
FIGURE 16 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 47
FIGURE 17 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 48
FIGURE 18 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2025 VS. 2030 (USD MILLION) 49
FIGURE 19 DEFIBRILLATOR MARKET, BY PATIENT TYPE, 2023 VS. 2030 49
FIGURE 20 DEFIBRILLATOR MARKET, BY END USER, 2025 VS. 2030 50
FIGURE 21 GEOGRAPHICAL SNAPSHOT OF DEFIBRILLATOR MARKET 51
FIGURE 22 RISING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET 52
FIGURE 23 HOSPITALS & CLINICS SEGMENT AND CHINA LED DEFIBRILLATOR MARKET
IN 2024 53
FIGURE 24 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD 54
FIGURE 25 DEFIBRILLATOR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
FIGURE 26 REVENUE SHIFT AND NEW REVENUE POCKETS FOR DEFIBRILLATOR MARKET 62
FIGURE 27 AVERAGE SELLING PRICE OF EXTERNAL DEFIBRILLATORS, BY KEY PLAYER,
2024 (USD) 63
FIGURE 28 DEFIBRILLATOR MARKET: VALUE CHAIN ANALYSIS 65
FIGURE 29 DEFIBRILLATOR MARKET: SUPPLY CHAIN ANALYSIS 66
FIGURE 30 DEFIBRILLATOR MARKET: ECOSYSTEM ANALYSIS 67
FIGURE 31 DEFIBRILLATOR MARKET: INVESTMENT AND FUNDING SCENARIO, 2019–2023 68
FIGURE 32 DEFIBRILLATOR MARKET: PATENT ANALYSIS, JANUARY 2014–JUNE 2025 71
FIGURE 33 DEFIBRILLATOR MARKET: PORTER’S FIVE FORCES ANALYSIS 82
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DEFIBRILLATOR 84
FIGURE 35 KEY BUYING CRITERIA FOR DEFIBRILLATOR, BY PRODUCT 85
FIGURE 36 DEFIBRILLATOR MARKET: AI USE CASES 89
FIGURE 37 NORTH AMERICA: DEFIBRILLATOR MARKET SNAPSHOT 135
FIGURE 38 ASIA PACIFIC: DEFIBRILLATOR MARKET SNAPSHOT 167
FIGURE 39 DEFIBRILLATOR MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS,
2022–2024 221
FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICDS) MARKET, 2024 222
FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN EXTERNAL DEFIBRILLATOR MARKET, 2024 223
FIGURE 42 RANKING OF KEY PLAYERS IN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, 2024 224
FIGURE 43 EV/EBITDA OF KEY VENDORS 225
FIGURE 44 YEAR-TO-DATE PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 225
FIGURE 45 DEFIBRILLATOR MARKET: BRAND/PRODUCT COMPARISON 226
FIGURE 46 DEFIBRILLATOR MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 227
FIGURE 47 DEFIBRILLATOR MARKET: COMPANY FOOTPRINT 228
FIGURE 48 DEFIBRILLATOR MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 232
FIGURE 49 MEDTRONIC: COMPANY SNAPSHOT (2024) 239
FIGURE 50 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 245
FIGURE 51 ABBOTT: COMPANY SNAPSHOT (2024) 249
FIGURE 52 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2024) 252
FIGURE 53 STRYKER: COMPANY SNAPSHOT (2024) 255
FIGURE 54 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 258
FIGURE 55 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 261
FIGURE 56 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2024) 265
FIGURE 57 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
COMPANY SNAPSHOT (2024) 268
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11